Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder
Open Access
- 17 March 2006
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 97 (5), 997-1001
- https://doi.org/10.1111/j.1464-410x.2006.06036.x
Abstract
OBJECTIVE To assess the contemporary inter‐institutional accuracy of urinary cytology in predicting the recurrence of transitional cell carcinoma (TCC) of the bladder, in a large multi‐institutional cohort from four continents, as cystoscopy and urinary cytology represent the ‘gold standards’ for surveillance of TCC recurrences, but the ability of cytology to predict recurrence varies. PATIENTS AND METHODS Ten institutions contributed 2542 patients with a history of superficial TCC, of whom 898 had TCC recurrence. Age‐ and gender‐adjusted logistic regression models were used to evaluate the association between urine cytology and TCC recurrence. The predictive accuracy derived from the logistic regression model was tested using the area under the receiver operating characteristic curve. The resulting predictive accuracy estimates were internally validated with 200 bootstrap re‐samples. RESULTS The mean (range across institutions) age of the patients was 65 (48–69) years and 75 (67–87)% were men. Cytology was positive in 19 (10–38)% of patients; recurrence was identified in 35 (27–54)% of patients. The sensitivity was 38–65% across institutions. Urinary cytology varied significantly in its ability to predict recurrence of bladder cancer. Institution‐specific predictive accuracy adjusted for gender and age was 0.627–0.893. Stratifying by grade and stage only partly attenuated the discrepancies between centres. CONCLUSIONS The variability of urinary cytology results was very appreciable among the 10 centres and ranged from poor (63%) to excellent (89%).Keywords
This publication has 16 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Differences Between Local and Review Urinary Cytology in Diagnosis of Bladder Cancer. An Interobserver Multicenter AnalysisEuropean Urology, 2002
- THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCERJournal of Urology, 2000
- THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCERJournal of Urology, 2000
- MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDYJournal of Urology, 2000
- MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER:Journal of Urology, 2000
- The accuracy of urinary cytology in daily practiceCancer, 1999
- Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1995
- Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1995
- Adjuvant Intravesicular Pharmacotherapy for Superficial Bladder CancerJNCI Journal of the National Cancer Institute, 1991